Bass, Berry & Sims attorney Shannon Wiley has been appointed to serve on the board of directors for the National Association of Specialty Pharmacy (NASP). Her term will run from October 2026 through September 2027. The mission of NASP is to empower specialty pharmacy stakeholders to advance the standard of patient care. It is the only national association representing all stakeholders in the specialty pharmacy industry. New board members were officially welcomed during the inSPire 2026 conference – the NASP annual meeting and expo. Visit the NASP website to learn more.
Shannon Wiley
Shannon focuses her practice on healthcare regulatory and transactional matters within the pharmaceutical industry, with particular experience advising specialty pharmacies, digital pharmacies, infusion providers, and other entities in the specialty drug channel. She counsels clients on a wide range of business and operational matters, including complex drug commercialization programs, pharmacy services agreements, 340B program compliance, direct to patient strategies, mergers & acquisitions, and other complex healthcare transactions. Drawing on a deep understanding of the industry, Shannon also advises on federal and state regulatory requirements, including board of pharmacy regulations, Medicare billing rules, the Anti-Kickback Statute, HIPAA, FDA regulations, and corporate practice of medicine considerations. Learn more about Shannon’s practice here.